Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut.

Acta Neuropathol · 2022 · PMC8732825 · PMID 34741635

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This was not observed in the duodenum, which only showed a trend towards decreased GFAP expression after UB-312 treatment, correlating with the lack of treatment effect on αSyn pathology.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.